| Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The lancet 399 (10332), 1303-1312, 2022 | 1060 | 2022 |
| Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 A Singanayagam, M Patel, A Charlett, JL Bernal, V Saliba, J Ellis, ... Eurosurveillance 25 (32), 2001483, 2020 | 982 | 2020 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 798 | 2022 |
| Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal … A Singanayagam, S Hakki, J Dunning, KJ Madon, MA Crone, A Koycheva, ... The lancet infectious diseases 22 (2), 183-195, 2022 | 783 | 2022 |
| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 755 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 669 | 2021 |
| Adverse impact of surgical site infections in English hospitals R Coello, A Charlett, J Wilson, V Ward, A Pearson, P Borriello Journal of Hospital Infection 60 (2), 93-103, 2005 | 638 | 2005 |
| Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection V Hall, S Foulkes, F Insalata, P Kirwan, A Saei, A Atti, E Wellington, ... New England Journal of Medicine 386 (13), 1207-1220, 2022 | 534 | 2022 |
| Fat, fish, fish oil and cancer CPJ Caygill, A Charlett, MJ Hill British Journal of Cancer 74 (1), 159-164, 1996 | 452 | 1996 |
| Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate … K Eastwood, P Else, A Charlett, M Wilcox Journal of clinical microbiology 47 (10), 3211-3217, 2009 | 412 | 2009 |
| Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism RJ Dobbs, A Charlett, AG Purkiss, SM Dobbs, C Weller, DW Peterson Acta Neurologica Scandinavica 100 (1), 34-41, 1999 | 402 | 1999 |
| Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study C Wloch, J Wilson, T Lamagni, P Harrington, A Charlett, E Sheridan BJOG: An International Journal of Obstetrics & Gynaecology 119 (11), 1324-1333, 2012 | 372 | 2012 |
| Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved … SP Stone, C Fuller, J Savage, B Cookson, A Hayward, B Cooper, ... Bmj 344, 2012 | 309 | 2012 |
| Duration of operation as a risk factor for surgical site infection: comparison of English and US data G Leong, J Wilson, A Charlett Journal of Hospital Infection 63 (3), 255-262, 2006 | 259 | 2006 |
| Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010 RG Pebody, E McLean, H Zhao, P Cleary, S Bracebridge, K Foster, ... Eurosurveillance 15 (20), 19571, 2010 | 236 | 2010 |
| Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies EJ Adams, A Charlett, WJ Edmunds, G Hughes Sexually transmitted infections 80 (5), 354-362, 2004 | 226 | 2004 |
| Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989–95 DCE Speller, AP Johnson, D James, RR Marples, A Charlett, RC George The lancet 350 (9074), 323-325, 1997 | 217 | 1997 |
| Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine I Stephenson, JM Wood, KG Nicholson, A Charlett, MC Zambon Virus research 103 (1-2), 91-95, 2004 | 211 | 2004 |
| The Feedback Intervention Trial (FIT)—improving hand-hygiene compliance in UK healthcare workers: a stepped wedge cluster randomised controlled trial C Fuller, S Michie, J Savage, J McAteer, S Besser, A Charlett, A Hayward, ... PloS one 7 (10), e41617, 2012 | 208 | 2012 |
| Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement N Field, T Cohen, MJ Struelens, D Palm, B Cookson, JR Glynn, V Gallo, ... The Lancet infectious diseases 14 (4), 341-352, 2014 | 196 | 2014 |
